Items where authors include "McGonagle, D."
Up a levelArticle
David, P. orcid.org/0000-0003-0075-5895, Di Matteo, A., Hen, O. et al. (9 more authors) (2024) <scp>Poly‐Refractory</scp> Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes. Arthritis & Rheumatology. ISSN 2326-5191
McGonagle, D. orcid.org/0000-0001-7715-8226, David, P. orcid.org/0000-0003-0075-5895, Macleod, T. orcid.org/0000-0002-7903-2990 et al. (1 more author) (2023) Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis. Nature Reviews Rheumatology, 19. pp. 818-827. ISSN 1759-4790
Ganguly, P. orcid.org/0000-0003-1042-5910, Macleod, T., Wong, C. et al. (2 more authors) (2023) Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i). Pharmaceuticals, 16 (9). 1286. ISSN 1424-8247
Cuthbert, R.J., Jones, E. orcid.org/0000-0001-9365-2283, Sanjurjo-Rodríguez, C. orcid.org/0000-0003-2702-7804 et al. (8 more authors) (2020) Regulation of Angiogenesis Discriminates Tissue Resident MSCs from Effective and Defective Osteogenic Environments. Journal of Clinical Medicine, 9 (6). 1628. ISSN 2077-0383
Ponchel, F., Verburg, R.J., Bingham, S.J. et al. (24 more authors) (2004) Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Research and Therapy, 7 (1). R80-R92. ISSN 1478-6362
Ponchel, F., Verburg, R.J., Bingham, S.J. et al. (24 more authors) (2004) Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Research & Therapy, 7 (1). R80-R92. ISSN 1478-6354
Wakefield, R.J., Green, M.J., Marzo-Ortega, H. et al. (5 more authors) (2004) Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Annals of the Rheumatic Diseases, 63 (Suppl ). pp. 382-385. ISSN 0003-4967
Conference or Workshop Item
McGonagle, D., Haaland, D., Helliwell, P. orcid.org/0000-0002-4155-9105 et al. (6 more authors) (2023) Improvement in Key PsA Core Domains With Guselkumab Treatment in an Enriched Population of ACR20 Non-responders at Week 24: Post Hoc Analysis of Two Phase 3 Studies. In: ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, PA.
Proceedings Paper
McGonagle, D., Haaland, D., Helliwell, P. et al. (6 more authors) (2022) 2113: Improvement in Key PsA Core Domains with Guselkumab Treatment in an Enriched Population of ACR20 Non-Responders at Week 24: Post Hoc Analysis of Two Phase 3 Studies. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. , pp. 4182-4184.
Preprint
Iqbal, K., Sinha, S., David, P. et al. (25 more authors) (2023) MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C). [Preprint]